Antares Pharma, Inc. (ATRS) will report its next earnings on Nov 05 BMO. The company reported the earnings of $0.01/Share in the last quarter where the estimated EPS by analysts was $-0.02/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 150%.
Many analysts are providing their Estimated Earnings analysis for Antares Pharma, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $-0.02/share and a High Estimate of $0/share.
In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Antares Pharma, Inc. as 31.54 Million. According to these analysts, the Low Revenue Estimate for Antares Pharma, Inc. is 30.2 Million and the High Revenue Estimate is 33.2 Million. The company had Year Ago Sales of 18.82 Million.
These analysts also forecasted Growth Estimates for the Current Quarter for ATRS to be -125%. They are projecting Next Quarter growth of 166.67%. For the next 5 years, Antares Pharma, Inc. is expecting Growth of 277.08% per annum, whereas in the past 5 years the growth was -100% per annum.
Some buy side analysts are also providing their Analysis on Antares Pharma, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Antares Pharma, Inc. might touch $9 high while the Average Price Target and Low price Target is $6.44 and $5 respectively.
Antares Pharma, Inc. closed its last trading session at $3.74 with the loss of -1.6%. The Market Capitalization of the company stands at 593.03 Million. The Company has 52-week high of $3.96 and 52-week low of $2.53. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.84% where SMA50 and SMA200 are 7.74% and 15.45% respectively. The Company Touched its 52-Week High on 03/04/19 and 52-Week Low on 12/28/18.
The Relative Volume of the company is 3.41 and Average Volume (3 months) is 889.84 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 23.29.
The company shows its Return on Assets (ROA) value of -3.8%. The Return on Equity (ROE) value stands at -9.7%. While it’s Return on Investment (ROI) value is -25.9%.
While looking at the Stock’s Performance, Antares Pharma, Inc. currently shows a Weekly Performance of 9.52%, where Monthly Performance is 13.58%, Quarterly performance is 12.54%, 6 Months performance is 26.46% and yearly performance percentage is 1.94%. Year to Date performance value (YTD perf) value is 35.29%. The Stock currently has a Weekly Volatility of 4.94% and Monthly Volatility of 3.64%.